ArticleFrontiers in oncology2021

Quantitative Proteomic Profiling Identifies a Potential Novel Chaperone Marker in Resistant Breast Cancer.

Karen M Gallegos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.